Cargando…

Routine Neuroimaging in Patients with Stage IV Non-Small Cell Lung Cancer: A Single Center Experience

Background: There is a lack of consensus in current practice guidelines regarding routine neuroimaging in patients with stage IV non-small cell lung cancer (NSCLC) without neurologic symptoms, and there is a paucity of data on the impact of such imaging on overall survival (OS). Methods: This retros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dubé-Pelletier, Maude, Labbé, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025755/ https://www.ncbi.nlm.nih.gov/pubmed/33801445 http://dx.doi.org/10.3390/curroncol28020108

Ejemplares similares

Pembrolizumab Every 6 Weeks Versus Every 3 Weeks in Advanced Non-Small Cell Lung Cancer
por: Dubé-Pelletier, Maude, et al.
Publicado: (2023)

Outcomes of patients with unresected stage III and stage IV non-small cell lung cancer: A single institution experience
por: Tiwana, Manpreet Singh, et al.
Publicado: (2013)

Surgery for stage IV non-small cell lung cancer?
por: Puig, Carlos A., et al.
Publicado: (2020)

Impact of neuroimaging in the pretreatment evaluation of early stage non-small cell lung cancer
por: Wasp, Garrett T., et al.
Publicado: (2020)

Stage IV Non-small Cell Lung Cancer Presenting as Supraventricular Tachycardia
por: Amin, Hina, et al.
Publicado: (2019)

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV
por: Akamatsu, Hiroaki, et al.
Publicado: (2019)

Neuroimaging Spectrum in COVID-19 Infection: A Single-Center Experience
por: Tiwari, Sarbesh, et al.
Publicado: (2023)

Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer
por: Cheruvu, Praveena, et al.
Publicado: (2011)

Immunotherapy in non-metastatic non-small cell lung cancer: Can the benefits of stage IV therapy be translated into earlier stages?
por: Deslypere, Griet, et al.
Publicado: (2018)

ROS1 rearrangement and response to crizotinib in Stage IV non-small cell lung cancer
por: Suryavanshi, Moushumi, et al.
Publicado: (2017)

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)
por: Assi, Hazem I., et al.
Publicado: (2023)

Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer
por: Liu, Xiaoli, et al.
Publicado: (2023)

Lung microbiota features of stage III and IV non-small cell lung cancer patients without lung infection
por: Zhang, Miao, et al.
Publicado: (2022)

Association between clinical outcomes and local treatment in stage IV non‐small cell lung cancer patients with single extrathoracic metastasis
por: Lim, Jeong Uk, et al.
Publicado: (2022)

Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: results of a prospective single-center study
por: Su, Sheng-Fa, et al.
Publicado: (2013)

Much has changed in the last decade except overall survival: A Swiss single center analysis of treatment and survival in patients with stage IV non-small cell lung cancer
por: Wallrabenstein, Till, et al.
Publicado: (2020)

Maintenance and Consolidation Therapy in Patients with Unresectable Stage III/IV Non-Small Cell Lung Cancer
por: Thatcher, Nicholas, et al.
Publicado: (2010)

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer
por: Simonetti, Sara, et al.
Publicado: (2010)

Second Complete Remission of Relapsed Stage IV Non-Small Cell Lung Cancer Following Retreatment
por: Yoo, Su Jin, et al.
Publicado: (2012)

Excision of the primary in stage IV non-small cell lung cancer (NSCLC): A feasibility study
por: Dawson, Alan G, et al.
Publicado: (2015)

EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond Progression
por: Van Assche, Katrijn, et al.
Publicado: (2014)

Prognostic Factors for Short‐term Survival in Patients with Stage IV Non‐small Cell Lung Cancer
por: Ando, Masahiko, et al.
Publicado: (1999)

Site of Metastases as Prognostic Factors in Unselected Population of Stage IV Non-Small Cell Lung Cancer
por: Badawy, Ahmed Ashour, et al.
Publicado: (2018)

Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer
por: Shishido, Stephanie N., et al.
Publicado: (2019)

Patterns of care for older patients with stage IV non‐small cell lung cancer in the immunotherapy era
por: Kehl, Kenneth L., et al.
Publicado: (2020)

Alectinib-associated pneumoperitoneum in stage IV non-small cell lung cancer - A case report
por: Maina, Renee M., et al.
Publicado: (2022)

Pain and Interventions in Stage IV Non-Small Cell Lung Cancer: A Province-Wide Analysis
por: Tan, Vivian S., et al.
Publicado: (2023)

Personal and clinical characteristics associated with immunotherapy effectiveness in stage IV non-small cell lung cancer
por: Patel, Krishna H., et al.
Publicado: (2023)

Impact of Liver Metastasis on First-Line Immunotherapy in Stage IV Non-Small Cell Lung Cancer
por: Komiya, Takefumi, et al.
Publicado: (2023)

Second-line Treatment of Stage III/IV Non-Small-Cell Lung Cancer (NSCLC) with pemetrexed in routine clinical practice: Evaluation of performance status and health-related quality of life
por: Schuette, Wolfgang, et al.
Publicado: (2012)

Survival Outcomes with Photodynamic Therapy, Chemotherapy and Radiation in Patients with Stage III or Stage IV Non-Small Cell Lung Cancer
por: Chhatre, Sumedha, et al.
Publicado: (2021)

A phase II study of single-agent gefitinib as first-line therapy in patients with stage IV non-small-cell lung cancer
por: Suzuki, R, et al.
Publicado: (2006)

Public health communication during the COVID-19 pandemic: perspectives of communication specialists, healthcare professionals, and community members in Quebec, Canada
por: Dubé, Ève, et al.
Publicado: (2022)

A Case of Small Cell Cancer of the Breast in a Male with Synchronous Stage IV Non-Small Cell Lung Carcinoma
por: Matt, Laurie, et al.
Publicado: (2013)

Survival of Black and White Patients With Stage IV Small Cell Lung Cancer
por: Shi, Huashan, et al.
Publicado: (2021)

Measurement of mid-arm muscle circumference and prognosis in stage IV non-small cell lung cancer patients
por: TARTARI, RAFAELA FESTUGATTO, et al.
Publicado: (2013)

A Case of Stage IV Non-Small Cell Lung Cancer Treated with Korean Medicine Therapy Alone
por: Lee, Dong-hyun, et al.
Publicado: (2013)

Radical thoracic radiotherapy may provide favorable outcomes for stage IV non‐small cell lung cancer
por: Wang, Jingbo, et al.
Publicado: (2015)

Glasgow Prognostic Score in Patients Receiving Chemotherapy for Non-small-cell Lung Cancer in Stages IIIb and IV
por: Umihanic, Sefika, et al.
Publicado: (2014)

Potential Influence on Clinical Trials of Long-Term Survivors of Stage IV Non-small cell Lung Cancer
por: Davis, Jennifer S, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_opr2eni51sb2886rj9icd8ttl5